SCDM Certification Program Reaches 500 CCDMs Worldwide
MILWAUKEE – The Society for Clinical Data Management announced that is has recently certified its 500th Certified Clinical Data Manager (CCDM).
The CCDM credential is an elite mark of excellence in and commitment to clinical data management. Approximately 160 CCDMs were certified in 2009, nearly 40% of whom live outside North America.
“The CCDM designation is recognized globally as a standard for quality data management staff,” said 2010 SCDM Chair Ralph J. Russo, CCDM. “It provides the clinical research industry with a measure of expertise.”
Since its inception in 2005, the Certified Clinical Data Manager program has enhanced the quality and professionalism of CDMs worldwide. To earn the CCDM credential, candidates must first meet minimum standards of education and experience, then pass a challenging exam testing knowledge of best practices in all areas of clinical data management. Once obtained, certification must be renewed every three years by completing education activities or retaking the exam.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
